Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Puredia is a biotechnology company specializing in the cultivation, research, and manufacturing of bioactive ingredients derived from organic Sea Buckthorn and other high-altitude superfoods. Based in Hong Kong with extensive operations on the Tibetan Plateau, the company utilizes proprietary supercritical CO2 extraction technology to produce high-purity extracts such as Omegia and CyanthOx. These ingredients are rich in rare nutrients like Omega-7 and potent antioxidants, targeting applications in skin health, eye care, and cardiovascular wellness. Puredia maintains a vertically integrated supply chain, ensuring sustainability and traceability from its 23,000-acre organic farm to the final product. The company serves the global nutraceutical, cosmeceutical, and functional food industries with clinically-supported natural solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Puredia.